| ||
| Big Pharma Tackles Lung Cancer; Biotech Helping, Too Motley Fool Eli Lilly's (NYSE: LLY ) Alimta is already approved to treat lung cancer, but data presented at ASCO suggests that using the drug longer can help keep the cancer at bay. After an initial treatment with Alimta, patients who continued on the drug saw ... See all stories on this topic » | ||
| Maintenance therapy reduces lung cancer recurrence Oncology Update By Sarah Colyer on 7 June 2011 Two new placebo-controlled trials successfully demonstrate the benefits of maintenance therapy in advanced lung cancer, raising serious concerns over the ethics of randomising patients to placebo. ... See all stories on this topic » | ||
| ||
| Silence Therapeutic's Atu027 shows promising results on cancer patients Proactive Investors UK Nine of 24 patients treated with it achieved "stable" disease after repeated treatment, said the firm. Among them, one patient with neuroendocrine cancer had the disease stabilised for 9 months. A second patient showed partial regression of lung cancer ... See all stories on this topic » | ||
| New Zealand-designed anti-tumour agent to enter clinical development HealthCanal.com In lung cancer patients for instance, approximately 50 percent of tumours have hypoxic regions. Hypoxic tumours are generally resistant to standard cancer therapies and currently there is no effective treatment for these tumours. ... See all stories on this topic » | ||
| Cancer: Genetic Mutations and Targeted Therapy KGO-AM ... cancer treatment, called targeted therapy. Researchers presented their findings Saturday at the annual meeting for the American Society of Clinical Oncology. In one new study, a consortium of 14 institutions analyzed lung tumors from 1000 patients. ... See all stories on this topic » | ||
| Semuloparin Thwarts Venous Thromboembolism In Patients Starting Chemotherapy Medical News Today The majority had lung (37%) or colon-rectum (29%) cancer. The median treatment duration was about 3.5 months. Twenty (1.2%) of the 1608 semuloparin-treated patients and 55 (3.4%) of the 1604 placebo-treated patients had a thromboembolic event, ... See all stories on this topic » | ||
| More breast cancer radiation therapy helps UPI.com There was a small but statistically significant increased risk of moderate lung inflammation and lymphedema -- excess lymphatic fluid -- in the arm on the radiated side. The findings were presented at the annual meeting of the American Society of ... See all stories on this topic » | ||
|
| ||
| Mutation-Specific Therapy in Lung Cancer: This is the Future June 6, 2011 (Chicago, Illinois) — The treatment of lung cancer is undergoing a revolution. The clinical guidelines for nonsmall-cell lung cancer have just ... www.medscape.com/viewarticle/744002 | ||
| Lung cancer treatment fundamentals explained | ArticleSnarf A variety of factors decide the course of treatment for lung cancer. Oncologists should initial verify the histopathologic type of the lung cancer and thus ... articlesnarf.com/.../lung-cancer-treatment-fundamentals-explai... | ||
| Lung cancer treatment tips » ArticlesCatalogue.org A variety of things decide the course of treatment for lung cancer. Oncologists should first verify the histopathologic sort of the lung cancer and so the. articlescatalogue.org/lung-cancer-treatment-tips/ | ||
| Targeted drug therapy found highly effective in lung cancer ... Washington, June 4: A study has revealed that a drug, crizotinib that targets a specific type of lung cancer has shown positive response in more than half ... www.indiatalkies.com/.../targeted-drug-therapy-highly-effecti... | ||
| How helpful is chemotherapy after surgery for lung cancer? - Sharecare Chemotherapy after lung cancer surgery is now recommended to all but the earliest ... Learn more from our experts about chemotherapy after lung cancer surgery. www.sharecare.com/.../how-chemotherapy-surgery-lung-canc... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment